Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis-Reference-Cited by-同舟云学术

Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis

Published:2014-06-20 Issue:1 Volume:78 Page:118-128
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Ternant David¹²³,Ducourau Emilie¹²³,Perdriger Aleth⁴,Corondan Anca⁵,Le Goff Benoît⁶,Devauchelle-Pensec Valérie⁷,Solau-Gervais Elisabeth⁸,Watier Hervé¹²³,Goupille Philippe¹²³⁹,Paintaud Gilles¹²³,Mulleman Denis¹²³⁹

Affiliation:

1. Université François Rabelais de Tours; GICC; Tours France

2. CNRS; UMR 7293; Tours France

3. CHRU de Tours; Tours France

4. CHRU de Rennes; Rennes France

5. CHR d'Orléans; Orléans France

6. CHRU de Nantes; Nantes France

7. Université de Bretagne Occidentale; EA 2216; CHRU de Brest; Brest France

8. CHRU de Poitiers; Poitiers France

9. INSERM; CIC 202; Tours France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12313/fullpdf

Reference24 articles.

1. The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial;St Clair;Arthritis Rheum,2002

2. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab;Bendtzen;Arthritis Rheum,2006

3. Trough infliximab concentrations predict efficacy and sustained control of disease activity in rheumatoid arthritis;Mulleman;Ther Drug Monit,2010

4. Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis;Wolbink;Ann Rheum Dis,2005

5. Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis;Fasanmade;Eur J Clin Pharmacol,2009

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geschlechtsspezifische Unterschiede in Diagnostik und Therapie entzündlich-rheumatischer Erkrankungen;Die Innere Medizin;2023-03-06

2. Population Pharmacokinetics of CMAB008 (an Infliximab Biosimilar) and Remicade® in Healthy Subjects and Patients with Moderately to Severely Active Rheumatoid Arthritis;Advances in Therapy;2023-01-06

3. Population Pharmacokinetics and Exposure–Response Analyses of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease;Clinical Therapeutics;2022-10

4. Modelling rheumatoid arthritis: A hybrid modelling framework to describe pannus formation in a small joint;ImmunoInformatics;2022-06

5. Nonlinear Population Pharmacokinetics of Anifrolumab in Healthy Volunteers and Patients With Systemic Lupus Erythematosus;The Journal of Clinical Pharmacology;2022-05-21